Baird Medical Investment Holdings Ltd (BDMD): Revenue

Annual figures by period end, from SEC filings.

$22.54M
Year ended 2025-12-31
-13.7%
3-year compound annual growth
$37.04M2022-12-31: $35.09M2023-12-31: $31.46M2024-12-31: $37.04M2025-12-31: $22.54M$22.54M
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$22.54M-39.2%2026-07-27, From 2025-01-01
2024-12-31$37.04M+17.7%2026-07-27, From 2024-01-01
2023-12-31$31.46M-10.4%2026-07-27, From 2023-01-01
2022-12-31$35.09Mn/a2025-05-15, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$22.54M-39.2%
DarioHealth Corp. (DRIO)2025-12-31$22.36M-17.3%
Spectral AI, Inc. (MDAI)2025-12-31$19.65M-33.6%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$19.53M+36.7%
Nephros Inc (NEPH)2025-12-31$18.79M+32.7%
Sensus Healthcare, Inc. (SRTS)2025-12-31$27.48M-34.3%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$17.44M+16.0%
Profound Medical Corp. (PROF)2025-12-31$16.10M+50.7%
Biotricity Inc. (BTCY)2026-03-31$16.00M+16.0%

Compare BDMD, DRIO, MDAI, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗